Respiratory Inhaler Devices Market

2019 Analysis and Review of Respiratory Inhaler Devices Market by Product - Dry Powder Inhaler, Metered Dose Inhaler, and Nebulizer for 2019 - 2029

  • 2020-02-19
  • REP-GB-493
  • 51 Tables
  • 76 Figures
  • 222 pages
  • PDF PPT EXCEL
Respiratory Inhaler Devices Market
  • SELECT LICENSE :

  • US$5,000
  • US$7,500
  • US$10,000

Respiratory Inhaler Devices Market Revenues to Exceed US$ 48 Bn in 2029

Healthcare is an ever-evolving and opportunity-rich industry. Upsurge in geriatric demographics around the world is translating into complex health requirements. Advent of technology is transforming the conventional ways of healthcare delivery, which is further pushing the clinical trials landscape. The ultimate objective is to achieve quality, accessibility, and cost-efficiency. This is creating a conducive environment for developing patient-centric and integrated healthcare ecosystems. Influenced by these trends, the global respiratory inhaler devices market will surpass revenues worth US$ 48 Bn by the end of forecast period (2019 - 2029).

COVID -19 : Impact Analysis

Request the coronavirus imapact analysis across industries and markets

Request Covid -19 Impact

Frequently asked questions about global respiratory inhaler devices market

Which region is expected to lead the global respiratory inhaler devices market?

North America is expected to dominate the global respiratory inhaler devices market in terms of revenue during the forecast period. Countries in Asia Pacific such as India and China, are expected to remain targeted geographies and provide numerous opportunities for regional and key players operating in the respiratory inhaler devices market.

Which product is expected to be most attractive in the respiratory inhaler devices market?

Dry powder inhalers are expected to hold above 50% of revenue share in the respiratory inhaler devices market, owing to its constant technological evolvement, better performance, and are most commonly used for drug delivery in asthma and COPD treatment.

Which disease indication segment is expected to dominate the respiratory inhaler devices market?

Asthma held significant market value share followed by COPD (chronic obstructive pulmonary disease) in the respiratory inhaler devices market and this trend is expected to continue during the forecast period, owing to extensive use of respiratory inhaler devices for asthma and COPD treatment.

Who are the major players contributing towards the growth of respiratory inhaler devices market?

Merck & Co. Inc., AstraZeneca Plc. Novartis AG, 3M Company, Boehringer Ingelheim GmbH, Cipla Ltd, and GlaxoSmithKline Plc. are the key players operating in the respiratory inhaler devices market. Introduction of new technologically advanced products and effective marketing are the key strategies practised by leading market players to improve their product portfolio and increase market share.

How do complications associated with the respiratory inhaler devices tend to hamper market growth?

The lack of awareness among patients regarding the use of new respiratory inhaler devices such as smart inhalers and soft mist inhalers, are expected to affect the overall growth of the respiratory inhaler devices market. Also, low treatment rate of asthma and COPD in middle- and low-income countries is anticipated to limit the respiratory inhaler devices market growth.

Dry Powder Inhalers Capture over 50% Value Share

Owing to greater precision and straightforward usage, dry powder inhalers (DPI) are leading the way in respiratory inhaler devices market. Such benefits of DPIs over other inhalers are enabling their broader adoption for drug delivery in asthma and chronic obstructive pulmonary disease (COPD) treatment. However, in due course of time, patients likely to switch from DPIs to metered dose inhalers (MDI) on grounds of reduced exacerbations and enhanced disease control. Despite this preferential shift, market players continue to reap higher returns from dry powder respiratory inhaler devices.

Strong Government Support Bolsters Market in North America, Europe, and APEJ

Factors such as conducive reimbursement policies, and notable upsurge in per capita healthcare spending would be critical in driving the respiratory inhaler devices market in both, developed and developing regions. Capturing a voluminous share in market revenues, collectively, North America and Europe continue to be the hotbed of investment opportunities for stakeholders in the respiratory inhaler devices market. Strong digital presence, particularly in these developed regions, is further attracting market players. Expanding unaddressed patient pool of asthma and COPD and government-backed awareness programs about the diseases in Asia Pacific (excluding Japan) are also creating white spaces to market players

* This data is only a representation. Actual data may vary and will be available in report.

Strong Government Support Bolsters Market in North America, Europe, and APEJ
Strong Government Support Bolsters Market in North America, Europe, and APEJ
Strong Government Support Bolsters Market in North America, Europe, and APEJ
Strong Government Support Bolsters Market in North America, Europe, and APEJ
  • 2014
  • 2018
  • 2022
  • 2029
  • Arrow

Strategic Collaboration for Superior Healthcare Delivery

Manufacturers of respiratory inhaler devices are focusing on strategic convening with digital and software service providers in order to address the expanding patient pool. Propeller Health, for instance, has partnered with Novartis International AG to develop a customized add-on sensor for their smart inhalers for treatment of COPD. AstraZeneca plc has created a digital health collaboration with Adherium for development of smart respiratory inhaler devices. Furthermore, players moving aggressively towards next-gen managed care model with meaningful engagement in healthcare delivery including, integration of a patients’ healthcare journey, will see bigger returns.   

Dry powder inhalers remain highly preferred

Metered dose inhalers to gather momentum

High demand for manually operated inhaler devices

Digitally operated inhaler devices to see steady adoption

High prevalence of asthma accounts for higher demand

COPD patient pool to underpin rapid sales growth

How Growth will Unfold

Preference for manually operated inhaler devices will remain intact in the respiratory inhaler devices market. 9 out of 10 patients opt for these respiratory inhaler devices, and the trend is likely to continue over the foreseeable timeframe. By 2026, manually operated inhaler devices worth over US$ 40 Bn would be used for treatment of asthma and COPD. However, market players are also citing revenue streams from digitally operated inhaler devices, especially in developed regions.

Respiratory Inhaler Devices Market Share by Technology

* This data is only a representation. Actual data may vary and will be available in report.

Click Here To Know How The Growth Will Unfold

Custom Market Research Services

FMI offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Overview

Respiratory Inhaler Devices Market Analysis 2019-2029

A recent market study published by Future Market Insights (FMI) on the respiratory inhaler devices market offers global industry analysis for 2014-2018 & opportunity assessment for 2019-2029. The report consists of a comprehensive assessment of the most important market dynamics. On conducting thorough research on the historical as well as current growth parameters of the respiratory inhaler devices market, growth prospects of the market are obtained with maximum precision. The report features unique and salient factors that may make a huge impact on the development of the respiratory inhaler devices market during the forecast period. It can help market players modify their manufacturing and marketing strategies to envisage maximum growth in the respiratory inhaler devices market in the coming years. The report provides detailed information about the current and future growth prospects of the respiratory inhaler devices market in the most comprehensive way for better understanding of readers.

Respiratory Inhaler Devices Market Taxonomy

FMI’s study on the respiratory inhaler devices market offers information divided into four important segments - product type, technology, disease indication, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Product

  • Dry Powder Inhalers
  •  Metered Dose Inhalers
  • Nebulizers
    • Compressed Air Nebulizers
    • Ultrasonic Nebulizers
    • Mesh Nebulizers

Technology

  • Manually Operated Inhaler Devices
  • Digitally Operated Inhaler Devices

Disease Indication

  • Asthma
  • Chronic Obstructive Pulmonary Disease
  • Pulmonary Arterial Hypertension
  • Others

Region

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • APEJ
  • Middle East and Africa (MEA)
  • Japan

What's Included

The report commences with the executive summary of the respiratory inhaler devices market report, which includes the summary of key findings and statistics of the market. It also includes the market value (US$ million) estimates of the leading segments of the respiratory inhaler devices market as well as the key trends impacting the market.

Readers can find detailed taxonomy and definition of the respiratory inhaler devices market, in this chapter, which helps readers to understand basic information about respiratory inhaler devices.

This section highlights the macroeconomic factors and the opportunities impacting the respiratory inhaler devices market, which will help readers to understand the market opportunities, based on which they can plan their strategies.

This chapter highlights the key dynamics of the respiratory inhaler devices market, which include drivers, restraints, and key market trends. This chapter is expected to enable readers to understand the factors that are propelling growth of the respiratory inhaler devices market, as well as those that are likely to hamper growth of the respiratory inhaler devices market.

The report covers the pricing analysis of the market based on region and other attributes in this chapter. It will help the reader find a comparative analysis of product pricing across different regions of the globe. Besides this section also highlights the epidemiology analysis and forecast of Asthma & COPD.

This section explains the global market value analysis and forecast for the respiratory inhaler devices market during the forecast period. Along with the historical market and opportunity analysis of the future. Readers can also find the absolute $ opportunity for the current year (2019), and an incremental $ opportunity for the forecast period (2019-2029).

This chapter explains how the respiratory inhaler devices market will grow across various geographic regions such as North America, Latin America, Western Europe, Eastern Europe, APEJ, Japan, and Middle East & Africa (MEA).

Based on product type, the respiratory inhaler devices market is segmented into dry powder inhaler, metered dose inhaler, and nebulizer. Nebulizer is further divided into three sub-segments compressed air nebulizers, ultrasonic nebulizers and mesh nebulizers. In this chapter, readers can find information and analysis of the market by different product type of respiratory inhaler devices and their growth during the forecast period.

Based on technology, the respiratory inhaler devices market is segmented into manually operated inhaler devices and digitally operated inhaler devices. In this chapter, readers can find information on market attractiveness analysis based on technology.

Based on disease indication, the respiratory inhaler devices market is segmented into asthma, chronic obstructive pulmonary disease, pulmonary arterial hypertension and other respiratory diseases (acute respiratory distress syndrome and fibrosis). In this chapter, readers can find information on market attractiveness analysis based on disease indication.

This chapter includes a detailed analysis of the growth of the North America respiratory inhaler devices market along with the country-wise assessment including the U.S. and Canada. Readers can also find key takeaways of this region, and market growth based on product type, technology, disease indication, and country of respiratory inhaler devices in the North America region.

This chapter includes the growth prospects of the respiratory inhaler devices market in leading countries such as Brazil, Mexico, Argentina, and the rest of Latin America. Readers can find thorough information about the growth parameters of the Latin America respiratory inhaler devices market during the period 2019-2029.

Important growth prospects of the respiratory inhaler devices market based on product type, technology, disease indication, and country in several Western European countries such as the Germany, the U.K, France, Italy, Spain, NORDIC, BENELUX, and rest of Western Europe are included in this chapter.

Detailed information about factors such as incremental opportunity, Y-O-Y growth, and regional trends that are impacting the growth of the Eastern Europe respiratory inhaler devices market are included in this chapter. It also includes the growth prospects of the respiratory inhaler devices market in leading Eastern European countries such as Poland, Russia.

China, India, Australia & New Zealand are the leading countries/regions in South Asia that are the prime subjects of assessment to obtain the growth prospects of the APEJ respiratory inhaler devices market. In this chapter, readers can find thorough information about the growth parameters of the APEJ respiratory inhaler devices market during the period.

This chapter provides information on how the respiratory inhaler devices market will grow in the major countries in the MEA region such as GCC Countries, South Africa, Northern Africa and Rest of MEA during the period.

This chapter consists of important parameters that have a huge impact on the growth of the respiratory inhaler devices market in Japan, based on market segmentation, during the forecast period. The chapter also provides an overview of the market growth of Japan respiratory inhaler devices market.

In this chapter, readers can find a comprehensive list of all the leading stakeholders in the respiratory inhaler devices market, along with detailed information about each company, including company overview, revenue shares, strategic overview, and recent company developments. Players featured in the respiratory inhaler devices market report include Aldo-Union S.A., Laboratorio Pablo Cassara S.r.l., Chiesi Farmaceutici S.p.A., Lupin Limited, Novartis AG, 3M Company, Merck & Company, Inc., GlaxoSmithKline Plc., Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim GmbH, Cipla Ltd, Koninklijke Philips N.V., Beximco Pharmaceuticals Ltd., Omron Corporation among others.

This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the report.

This chapter helps readers understand the research methodology followed to obtain various conclusions, important qualitative information, and quantitative information about the respiratory inhaler devices market.

How the research was conducted?

Primary Research

  • C - Level Executives
  • Marketing Directors
  • Product Managers 
  • Business Development Officers 
  • Production Managers
  • Procurement Heads
  • Sales Executives
  • Distributors
  • Traders 
  • Raw Material Suppliers
  • Industry Experts
  • End Users
  • Current Market Dynamics and Challenges
  • Yesteryear Trends 
  • Market Characteristics
  • Market Performance and Growth Quadrants
  • Competition Structure and Market Structure
  • Strategic Growth Initiatives
  • Near-term and Long-term Market Growth Prospects
  • Market Segment Splits and Authenticity
  • Opinions on Market Projections and Validity of Assumptions

Secondary Research

  • Industry Publications
    • World Health Organizations (WHO)
    • Global Asthma Report
    • National Institute of Health (NIH)
    • U.S. Food and Drug Administration (USFDA)
    • European Respiratory Society
  • Factiva
  • Company Press Releases
  • Annual Reports and Investor Presentations
  • Research Papers
  • Government Websites and Publications
  • Company Websites
  • Morningstar

Primary Interview Splits

Primary Interview Splits respiratory inhaler devices market designation

Primary Interview Splits respiratory inhaler devices market stakeholder

To Learn More About our Comprehensive Perspective on Respiratory Inhaler Devices Market,

Get in touch

Harish Tiwari

Harish Tiwari

Global Head - Business Development

* indicates mandatory fields

Our Clients


CASE STUDIES

See how our work makes an impact.

At FMI, we design strategies that are adaptive, impactful, and implementable.

Request Sample Ask An Analyst Request Methodology